Does Tolbutamide Interact with Dantrolene?
Tolbutamide and Dantrolene have a moderate drug interaction according to U.S. FDA drug labeling data. Tolbutamide increases binding of dantrolene to plasma proteins, potentially decreasing free drug concentration. The mechanism involves increased plasma protein binding. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Tolbutamide and Dantrolene occurs because increased plasma protein binding. Clinically, this means tolbutamide increases binding of dantrolene to plasma proteins, potentially decreasing free drug concentration. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Tolbutamide and your doctor is considering prescribing Dantrolene (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider